P53 gene mutation in cerebral primitive neuroectodermal tumor in Taiwan

Cancer Letters

Volumn 104, Issue 1, 1996, Pages 103-113

  Ho, Yat Sen ^a   Hsieh, Ling Ling ^a   Chen, Jen Shi ^a   Chang, Chen Nen ^a   Lee, Shih Tseng ^a   Chiu, Li Ling ^a   Chin, Ting Yu ^a   Cheng, Su Chu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Brain tumor; P53 gene; PCR SSCP; Primitive neuroectodermal tumor

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; HUMAN; HUMAN TISSUE; INFANT; MALE; NERVE CELL DIFFERENTIATION; NEUROECTODERM TUMOR; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TAIWAN; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

EID: 0029885840     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04238-3     Document Type: Article

References (37)

1. Agamanolis, D.P., Dasu, S. and Krill, C.E. (1986) Tumors of skeletal muscle. Hum. Pathol., 17, 778-795.
2. Becker, L.E. and Hinton, D. (1983) Primitive neuroectodermal tumors of the central nervous system. Hum. Pathol., 14, 538-550.
3. Binger, S.H. and Vogelstein, B. (1990) Cytogenetics and molecular genetics of malignant gliomas and medulloblastoma. Brain Pathol., 1, 12-18.
4. Boesel, C.P., Suhan, J.P. and Bradel, E.J. (1978) Ultrastructure of primitive neuroectodermal neoplasms of the central nervous system. Cancer, 42, 194-201.
5. Boyd, J.A. and Barrett, J.C. (1990) Tumor suppressor genes: possible functions in the negative regulation of cell proliferation. Mol. Carcinogen., 3, 325-329.
6. von Deimling, A., Eibl, R.H., Ohgaki, H., Louis, D.N., von Ammon, K., Petersen, I., Kleihues, P., Chung R.Y., Wiestler O.D. and Seizinger, B.R. (1992) p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res., 52, 2987-2990.
7. Dubeau, L., Chandler, L.A., Gralow, J.R., Nichols, P.W. and Jones, P.A. (1986) Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. Cancer Res., 46, 2964-2969.
8. Duffner, P.K., Cohen, M.E., Heffner, R.R. and Freeman, A.I. (1981) Primitive neuroectodermal tumors of childhood: an approach to therapy. J. Neurosurg., 55, 376-381.
9. Eiyahu, D., Michalovitz, D., Eiyahu, S., Pinhash-Kimni, O. and Oren, M. (1989) Plasmids encoding wild type p53 can inhibit oncogenic-mediated transformation. Proc. Natl. Acad. Sci. USA, 86, 8763-8767.
10. Finlay, C., Hinds, P. and Levine, A.J. (1989) The p53 protooncogene can act as a suppressor of transformation. Cell, 57, 1083-1093.
11. Frankel, R.H., Bayona, W., Koslow, M. and Newcomb, E.W. (1992) p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res., 52, 1427-1433.30.
12. Fromentel, C.C. and Soussi, T. (1992) TP53 tumor suppressor gene: a model for investigating human mutagenesis. Gene Chromosome Cancer, 4, 1-15.
13. Fujita, H. and Fujita, S. (1963) Electron microscopic studies on neuroblast differentiation in the central nervous system of domestic fowl. Z. Zellforsch., 60, 436-478.
14. Fults, D., Brockmeyer, D., Tullous, M.W., Pedone, C.A., Cawthon, R.M. (1992) p53 mutation and loss of heterozygosity on chromosome 17 and 10 during human astrocytoma progression. Cancer Res., 52, 674-679.
15. Gaffnet, C.C., Sloane, J.P., Bradley, N.J. and Bloom, H.J.G. (1985) Primitive neuroectodermal tumors of cerebrum, pathology and treatment. J. Neurooncol., 3, 23-33.
16. Hart, M.N. and Earle, K.M. (1973) Primitive neuroectodermal tumors of the brain in children. Cancer, 32, 890-897.
17. Ho, Y.S. (1995) Primitive neuroectodermal tumor. In: Pathology of The Brain Tumor, pp. 1-22. Editor: Y.S. Ho, Hwa-Hsiang Yuan, Taipei, Taiwan.
18. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers. Science (Washington, DC), 253, 49-53.
19. Hollstein, M.C., Peri, L., Mandard, A.M., Welsh, J.A., Montesano, R., Metcalf, R.A., Bak, M. and Harris, C.C. (1991) Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res., 51, 4102-4106.
20. Horten, B.C. and Rubinstein, L.J. (1976) Primary cerebral neuroblastoma. Brain, 99, 735-756.13.
21. Hsu, S.M., Raine, L. and Fanger, H. (1981) A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Pathol., 75, 734-738.
22. Kaplan, E.L. and Meier, P. (1981) Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc., 53, 547-581.
23. Levine, A.J., Momand, J. and Finlay, C.A. (1991) The p53 tumor suppressor gene. Nature (London), 351, 453-456.
24. Nigro, J.M., Baker, S.J. and Preisinger, A.C. (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature (London), 342, 705-708.
25. Ohgaki, H., Eibl, R.H., Wiestler, O.D., Yasargil, M.G., Newcomb, E.W. and Kleihues, P. (1991) p53 mutations in nonastrocytic human brain tumors. Cancer Res., 51, 6202-6205.
26. Orita, M., Suzuki, Y., Sekiya, T. and Hayashi, K. (1989) Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874-879.
27. Parham, D.M., Dias, P., Kelly, D.R., Rutledge, J.C. and Houghton, P. (1992) Desmin positivity in primitive neuroectodermal tumors of childhood. Am. J. Surg. Pathol., 16, 483-492.
28. Pigott, T.J.D., Punt, J.A.G., Lowe, J.S., Hendersin, M.J., Beck, A. and Gray, T. (1990) The clinical, radiological and histiopathologic features of cerebral primitive neuroectodermal tumor. Br. J. Neurosurg., 4, 287-298.
29. Prosser, J., Thompson, A.M., Cranston, G. and Evans, H.J. (1990) Evidence that p53 behaves as a tumor suppressor gene in sporadic breast tumors. Oncogene, 5, 1573-1579.
30. Rorke, L.B., Giles, F.H., Davis, R.L. and Becker, L.E. (1985) Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer, 56, 1869-1886.
31. Rorke, L.B. (1983) The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J. Neuropathol. Exp. Neurol., 42, 1-15.
32. Rubinstein, L.J. (1972) Cytogenesis and differentiation of primitive central neuroepithelial tumors. J. Neuropathol. Exp. Neurol., 31, 7-26.
33. Saylors, III, R.L., Sidransky, D., Friedman, H.S. Bigner, S.H., Bigner, D.D., Vogelstein, B. and Brodeur, G.M. (1991) Infrequent p53 gene mutation in medulloblastomas. Cancer Res., 51, 4721-472.
34. Scheurlen, W., Petrasch, K., Huppertz, H.-I. and Kuhl, J. (1993) Expression of mutant p53 protein in metastasizing medulloblastoma and PNET: a prognostic marker ? Am. J. Pediatr. Hematol Oncol., 15, 137-138.
35. Seemayer, T.A. and Cavenee, W.K. (1989) Molecular mechanisms of oncogenesis. Lab. Invest., 60, 585-599.
36. Sidransky, D., Mikkelsen, T., Schwechheimen, K., Roseablum, M.L., Cavanee, W. and Vogelstein, B. (1992) Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature, 355, 846-847.
37. Thomas, G.A. and Raffel, C. (1991) Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors. Cancer Res., 51, 639-643.